Millennium Management »

Polaryx Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Polaryx Therapeutics shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Polaryx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Polaryx Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Polaryx Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $964k 128k 7.56

More positions owned by Millennium Management

Astrazeneca Ord Put Option (AZN)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Put Option (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon Call Option (AMZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Select Sector Spdr Tr State Street Fin Put Option (XLF)
Broadcom (AVGO)
Select Sector Spdr Tr State Street Ene Call Option (XLE)

View all positions for Millennium Management

Top funds holding Polaryx Therapeutics

Vanguard Capital Management
Geode Capital Management
Millennium Management
Vanguard Fiduciary Trust
BlackRock
Bank of America Corporation
Goldman Sachs Group
UBS Group
Squarepoint Ops
Vanguard Global Advisers
Morgan Stanley

View all funds holding Polaryx Therapeutics